Introduction
Uterine fibroids are noncancerous growths that develop in or on the muscular wall of the uterus. They are made of smooth muscle cells and fibrous connective tissue, and they arise from the normal uterine muscle layer rather than from the lining of the uterus. In biological terms, fibroids are benign tumors of the myometrium, the thick muscular tissue that allows the uterus to contract.
These growths vary widely in size, number, and location. Some remain microscopic, while others enlarge enough to distort the shape of the uterus. Their behavior is driven by the interaction of uterine muscle cells with ovarian hormones, local growth signals, blood vessel formation, and the extracellular matrix that supports tissue structure. Understanding fibroids requires looking at how uterine smooth muscle cells respond abnormally to signals that normally regulate growth and repair.
The Body Structures or Systems Involved
The primary structure involved in uterine fibroids is the uterus, especially the myometrium, which is the middle muscular layer of the uterine wall. The uterus also contains the endometrium, the inner lining that thickens and sheds during the menstrual cycle, and the serosa, the outer covering. Fibroids may grow within the wall itself, project toward the uterine cavity, or extend outward from the outer surface.
The myometrium is composed of smooth muscle cells arranged in layers. In a healthy uterus, these cells contract during menstruation and childbirth and remain relatively quiet during most of the menstrual cycle. Their growth and activity are influenced by estrogen and progesterone, the main ovarian hormones, as well as by local signaling molecules such as growth factors, cytokines, and transforming growth factor beta. The normal balance among these signals keeps the uterine wall structurally stable while allowing controlled changes across the reproductive years.
Fibroids are also linked to the hormone-producing endocrine system, especially the ovaries, because their growth is strongly hormone responsive. The blood vessel network of the uterus is involved as well, since fibroids develop within a tissue that is highly dependent on circulation. In addition, the extracellular matrix, a meshwork of proteins such as collagen that supports cells, plays an unusually large role in fibroid structure and size. Many fibroids contain more matrix than normal uterine muscle tissue, which makes them firm and contributes to their distinct physical properties.
How the Condition Develops
Fibroids begin when a single smooth muscle cell in the myometrium acquires changes that allow it to grow in an abnormal and self-sustaining way. In many cases, the initiating event appears to involve genetic alterations in that cell. Some fibroids contain mutations in genes that regulate cell growth and chromatin structure, which affects how DNA is packaged and how genes are turned on or off. Once such a cell gains a growth advantage, it multiplies into a clone of similar cells that forms a fibroid mass.
After initiation, the fibroid does not grow simply because cells divide faster. The surrounding tissue environment changes as well. Fibroid cells produce increased amounts of extracellular matrix, which makes the lesion denser and more fibrous than normal uterine muscle. This matrix is not passive scaffolding; it affects how cells sense pressure, stretch, and chemical signals. In fibroids, the matrix helps reinforce abnormal growth by altering mechanical signaling and by trapping growth factors that encourage further tissue expansion.
Hormonal signaling is central to this process. Fibroids are sensitive to estrogen and progesterone, and their cells often have altered responses to both hormones. Rather than functioning only as cyclical reproductive regulators, these hormones can stimulate fibroid cell survival, matrix production, and growth factor activity. This is one reason fibroids tend to develop and enlarge during the reproductive years, when ovarian hormone production is active, and often shrink after menopause, when estrogen and progesterone levels fall.
Local signaling pathways also shape fibroid development. Growth factors such as platelet-derived growth factor, epidermal growth factor, and transforming growth factor beta help drive cell proliferation and matrix deposition. These signals are produced by fibroid cells themselves and by nearby stromal and immune cells, creating a microenvironment that supports continued growth. Blood vessels within and around the fibroid may also respond differently from those in normal uterine tissue, affecting oxygen delivery and tissue remodeling.
Structural or Functional Changes Caused by the Condition
The most obvious structural change is the formation of a firm, well-circumscribed mass within the uterus. Fibroids can enlarge the uterus, change its contour, and alter the relationship between the uterine cavity and surrounding structures. Their appearance depends on how much smooth muscle proliferation has occurred and how much extracellular matrix has accumulated. A fibroid rich in matrix may feel rubbery or firm, while one with degenerative changes may become softer or irregular.
As fibroids grow, they can outpace their blood supply. Because the tissue becomes bulky and dense, oxygen delivery may become insufficient in some regions. This can lead to degeneration, including hyaline change, calcification, cystic change, or red degeneration, which are forms of tissue breakdown or remodeling within the fibroid. These changes reflect altered circulation, tissue stress, and cell injury rather than a separate disease process.
Fibroids also influence the normal mechanics of the uterus. The muscular wall may contract differently because the tissue architecture has been replaced or distorted by fibroid nodules. The presence of excess extracellular matrix can make the uterine wall less compliant, meaning it does not stretch or contract in the same coordinated way as healthy myometrium. Fibroids that extend toward the uterine cavity can alter the shape and function of the endometrium, the tissue responsible for cyclic menstrual changes.
On a physiological level, fibroids can affect local blood flow and signaling between the endometrium and myometrium. The uterine lining depends on tightly regulated hormonal and vascular changes each cycle. When fibroids distort the wall or cavity, they can interfere with that normal coordination. The result is not just a mass lesion but a change in the organ’s overall structure and function.
Factors That Influence the Development of the Condition
Genetic predisposition plays a major role in fibroid development. Fibroids are more common in some families, suggesting inherited susceptibility to the cellular changes that allow myometrial cells to proliferate abnormally. At the molecular level, fibroid cells often show mutations or altered expression in genes related to growth control, hormone response, and chromatin remodeling. These changes do not act alone, but they help create a tissue environment in which a fibroid can arise.
Hormonal regulation is another major influence. Estrogen and progesterone do not usually create fibroids on their own, but they strongly shape whether fibroid cells grow and how much matrix they produce. Fibroid tissue often contains higher levels of hormone receptors than surrounding myometrium, which increases its responsiveness. This hormone sensitivity helps explain why fibroids are typically active during the reproductive years and less active after menopause.
Biological ancestry is also associated with fibroid risk, likely through a combination of genetic variation and differences in hormone signaling or tissue response. This reflects underlying physiology rather than a single cause. Environmental and metabolic factors may influence the hormonal or inflammatory setting in which fibroids develop. For example, body fat contributes to estrogen metabolism, because adipose tissue can convert androgens into estrogenic compounds. That can change the local and systemic hormonal environment that fibroids respond to.
Immune and inflammatory signaling may also participate in fibroid development. Fibroid tissue often contains immune cells and inflammatory mediators that interact with growth pathways. These signals may not cause the condition directly, but they can modify tissue repair and remodeling in ways that favor fibroid persistence. Mechanical stress in the uterine wall may likewise influence growth by activating pathways that respond to stretching and tissue tension.
Variations or Forms of the Condition
Fibroids are classified mainly by where they develop in relation to the layers of the uterus. Intramural fibroids grow within the muscular wall itself and are the most common form. Submucosal fibroids project toward the uterine cavity beneath the endometrium and are often the most disruptive to the cavity’s shape. Subserosal fibroids grow outward from the outer surface of the uterus, and some become attached by a stalk, forming pedunculated fibroids.
These forms arise from differences in the location of the initiating smooth muscle cell and the direction of growth. A fibroid’s position affects how it interacts with adjacent tissues, blood supply, and uterine mechanics. A small submucosal fibroid may have a greater functional impact on the uterine cavity than a larger subserosal fibroid because of its proximity to the endometrium. By contrast, an intramural fibroid may mainly change the thickness and contractility of the uterine wall.
Fibroids also vary in size and number. Some people develop a single dominant fibroid, while others form multiple nodules throughout the uterus. Multiple fibroids suggest that more than one smooth muscle cell lineage has undergone abnormal growth, or that a single altered tissue environment has supported several clonal expansions. Size varies depending on growth rate, hormone sensitivity, matrix accumulation, and whether the fibroid develops degenerative changes.
In addition to structural differences, fibroids can differ in their biological activity. Some are highly responsive to hormones and growth factors, while others remain relatively stable for long periods. These differences reflect variation in receptor levels, gene expression, extracellular matrix composition, and blood supply. The result is a condition that can look very different from one person to another even though the underlying tissue type is the same.
How the Condition Affects the Body Over Time
Over time, fibroids may remain stable, enlarge gradually, or undergo periods of faster growth and slower change. Their long-term behavior depends on hormonal exposure, tissue architecture, and the balance between cell proliferation and degeneration. Many fibroids grow during years of active ovarian function and later stop growing when hormone levels decline. Some decrease in size after menopause because the hormonal environment no longer supports the same degree of growth.
Persistent fibroids can lead to chronic remodeling of the uterus. As the tissue architecture becomes more altered, the organ may respond with changes in contractility, blood vessel distribution, and matrix turnover. The uterus is a dynamic organ, but fibroid tissue is less dynamic than normal myometrium because of its dense cellular and fibrous composition. This can create lasting structural distortion even if the fibroid does not continue to enlarge rapidly.
Complications over time are usually related to mass effect, distortion of the uterine cavity, or tissue degeneration. Larger fibroids may press on nearby organs simply because of their size and position. Fibroids that distort the cavity can interfere with the normal relationship between the endometrium and the uterine wall. In some cases, the fibroid tissue itself may outgrow its blood supply and develop degenerative changes, which reflect localized ischemia and breakdown within the mass.
Because fibroids are a chronic structural change in a hormone-sensitive organ, they can influence the broader physiology of the reproductive system. They are not a transient inflammatory lesion and not a malignant growth, but rather a benign expansion of uterine muscle cells supported by excess matrix and sustained by growth signaling. Their effects accumulate through anatomy and tissue mechanics more than through systemic illness.
Conclusion
Uterine fibroids are benign tumors of the uterine muscle, formed from smooth muscle cells and fibrous connective tissue in the myometrium. They develop through clonal growth of altered cells, hormone responsiveness, growth factor signaling, and accumulation of extracellular matrix. Their structure, location, and biological activity determine how they behave in the uterus and how they change the organ over time.
Understanding fibroids means understanding the uterus as a hormone-responsive muscular organ whose cells can respond abnormally to genetic change, local signaling, and tissue stress. The condition is defined not just by the presence of a mass, but by the way that mass arises from altered cellular growth and remodeling within uterine tissue. That biological framework explains why fibroids are common, variable, and closely tied to reproductive physiology.